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FIG S1 – Microbial community analysis of CF sputum by nonmetric multidimensional scaling 
(NMDS; Stress=0.11) analysis of the NanoString data.​ Black lines connect each sample to the centroid 
of the Patient ID. The outline of all samples from a single Patient ID is indicated by dotted lines. 
Weighted species abundances (percentage value^0.25) were used to calculate Bray-Curtis dissimilarity. 
Patient ID contributed 82% to the observed variance in the dataset (PERMANOVA; p < 0.001).  
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FIG S2 – ​The amount of ​anteiso fatty acids detected in CF sputum has a moderately positive                 
correlation with microbial producers of ​anteiso fatty acids. Abundance of ​anteiso fatty acids relative              
to NanoString ribosomal RNA counts. Panels for ​S. aureus​, ​S. maltophilia and ​P. melaninogenica​, as             
well as the combined counts of all three strains, are shown for all samples of the longitudinal dataset. 
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 TABLE S1 ​ Study participant demographic information 
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 TABLE S2 ​Additional information about study participants  
 
*MSSA = Methicillin sensitive ​Staphylococcus aureus​, PA = ​Pseudomonas aeruginosa 
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TABLE S2 (continued) ​Additional information about study participants  
 
* N: not detected in culture 
N/A indicates instances where no data was available 
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